Soeltl R - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

Krüger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N, Gänsbacher B, Schmitt M. Krüger A, et al. Among authors: soeltl r. Cancer Res. 2001 Feb 15;61(4):1272-5. Cancer Res. 2001. PMID: 11245418

Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.

Della Porta P, Soeltl R, Krell HW, Collins K, O'Donoghue M, Schmitt M, Krüger A. Della Porta P, et al. Among authors: soeltl r. Anticancer Res. 1999 Sep-Oct;19(5B):3809-16. Anticancer Res. 1999. PMID: 10628317

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M. Krüger A, et al. Among authors: soeltl r. Cancer Gene Ther. 2000 Feb;7(2):292-9. doi: 10.1038/sj.cgt.7700144. Cancer Gene Ther. 2000. PMID: 10770639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters